Task: Answer the MCQ question.
Query: Which drug exhibits a -26.750\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(C(=O)Nc2ccccc2Br)c1
b CCOC(=O)c1cc(C(O)(C(F)(F)F)C(F)(F)F)c(/N=C/N(C)C)o1
Answer: a. CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(C(=O)Nc2ccccc2Br)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(C(=O)Nc2ccccc2Br)c1
CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(C(=O)Nc2ccccc2Br)c1
N-(2-bromophenyl)-5-(dimethylsulfamoyl)-2-pyrrolidin-1-ylbenzamide